Researchers from Rice University and the University of Texas Health Science Center have developed immunotherapy drugs embedded in a slow-release hydrogel to treat cancer. Named STINGel, the product includes a new immunotherapy drug class called […]
Looking back over the last 15 years of Alzheimer’s disease (AD) research, it can seem that there’s scant room for hope. There is currently no cure for this debilitating neurodegenerative disease, and the current approved […]
The first consumer test for three BRCA gene mutations associated with breast, ovarian and prostate cancer risk has been approved by the U.S. Food and Drug Administration. The three gene mutations are most common in […]
Y-traps are Y-shaped molecules that are fused to a molecular ‘trap’ to capture nearby molecules and make them ineffective. A major way tumors evade the immune system is via regulatory T cells (Tregs) that […]
Biotechnology company Rubius Therapeutics has announced that it has raised $100 million from investors to go towards developing red blood cell therapies that can be used to combat cancer and rare enzyme deficiencies. The company […]